Memorial Sloan Kettering Cancer Center Dept. of MSKCC

New York, New York 90033

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma — Completed
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed